Surface modification technologies have been successfully used for more than a decade across multiple device applications to reduce risk of thrombosis, bacterial adhesion and biofouling. In this webinar, Jeannette Ho, one of the core principal developers of the market-leading Endexo®
surface modification technology, shared key tips on how medical device companies can enhance device functionality and biocompatibility while minimizing disruption to standard manufacturing processes and accelerating speed to market. Topics include:
- Patient risks for thrombus formation, bacterial adhesion and biofouling
- Key polymer and manufacturing process compatibility requirements
- How platforms require structural and chemical versatility to address specific application requirements
- Clinical outcomes from customer studies with devices approved for cardiovascular and urinary applications
Recent advances in biomaterials are helping to enhance the safety, biocompatibility and performance of implantable medical devices across a range of application areas, and also accelerate speed to market. As a global leader for bioresorbable polymers, surface modification technologies and application services, we hosted a special webinar series featuring some key opinion leaders.
Entitled “Biomaterial solutions for implantable medical device applications”
, the series covered a range of topics that are of growing interest to medical device companies across application areas including orthopedics, wound healing and cardiovascular care. Each live webinar was short, focused and gave participants an opportunity to ask questions directly to our experts.
Webinars which were part of the series are: